Sort:
Open Access Original Article Issue
Babesia infection in cattle and dogs in Suizhou City, Hubei Province, China
Infectious Medicine 2025, 4(1): 100170
Published: 01 March 2025
Abstract PDF (896.3 KB) Collect
Downloads:73
Background

Babesiosis is a zoonotic disease caused by the intraerythrocytic parasite Babesia, which poses a serious threat to public health. Currently, the prevalence of babesiosis in domestic animals and the genetic diversity of Babesia in Central China have not been comprehensively studied.

Methods

In this study, we collected 1093 ticks, including 95.24% (1041/1093) Haemaphysalis longicornis, 4.67% (51/1093) Rhipicephalus microplus, and 0.09% (1/1093) Ixodes sinensis. Blood samples from 216 goats, 56 cattle, and 25 dogs were collected from Suizhou City, Hubei Province, China, and animal blood DNA was extracted for the detection of Babesia with PCR.

Results

PCR results showed that 50.00% (28/56) of cattle and 32.00% (8/25) of dogs were Babesia-positive, including for Babesia bovis 3.57% (2/56), B. bigemina 3.57% (2/56), and B. ovata 42.86% (24/56) in cattle and B. gibsoni 32.00% (8/25) in dogs. All goats (216) and ticks (1093) were Babesia-negative.

Conclusions

Our findings showed that Babesia infections are prevalent in cattle and dogs in Central China, indicating that babesiosis should be monitored in animals and humans in Central China.

Open Access Editorial Issue
The Infectious Medicine is becoming a globally high-level scientific journal
Infectious Medicine 2024, 3(1): 100091
Published: 17 February 2024
Abstract PDF (237.2 KB) Collect
Downloads:41
Open Access Review Issue
Global trends in COVID-19
Infectious Medicine 2022, 1(1): 31-39
Published: 04 March 2022
Abstract PDF (1.2 MB) Collect
Downloads:152

The pandemic COVID-19 is certainly one of the most severe infectious diseases in human history. In the last 2 years, the COVID-19 pandemic has caused over 418.6 million confirmed cases and 5.8 million deaths worldwide. Young people make up the majority of all infected COVID-19 cases, but the mortality rate is relatively lower compared to older age groups. Currently, about 55.04% individuals have been fully vaccinated rapidly approaching to herd immunity globally. The challenge is that new SARS-CoV-2 variants with potential to evade immunity from natural infection or vaccine continue to emerge. Breakthrough infections have occurred in both SARS-CoV-2 naturally infected and vaccinated individuals, but breakthrough infections tended to exhibit mild or asymptomatic symptoms and lower mortality rates. Therefore, immunity from natural infection or vaccination can reduce SARS-CoV-2 pathogenicity, but neither can completely prevent SARS-CoV-2 infection/reinfection. Fortunately, the morbidity and mortality of COVID-19 continue to decline. The 7-day average cumulative case fatality of COVID-19 has decreased from 12.3% on the February 25, 2020, to 0.27% on January 09, 2022, which could be related to a decreased SARS-CoV-2 variant virulence, vaccine immunization, and/or better treatment of patients. In conclusion, elimination of SARS-CoV-2 in the world could be impossible or at least an arduous task with a long way to go. The best strategy to prevent COVID-19 pandemic is to expand inoculation rate of effective vaccines. As the population reaches herd immunity, the mortality rate of COVID-19 may continue to decrease, and COVID-19 could eventually become another common cold.

Open Access Editorial Issue
The inauguration of Infectious Medicine
Infectious Medicine 2022, 1(1): 1
Published: 10 January 2022
Abstract PDF (222.8 KB) Collect
Downloads:36
Open Access Original Article Issue
Oral and ocular transmission of severe fever with thrombocytopenia syndrome virus
Infectious Medicine 2022, 1(1): 2-6
Published: 10 January 2022
Abstract PDF (547.5 KB) Collect
Downloads:78
Background

Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne bunyavirus that could cause a severe hemorrhagic fever termed SFTS with a high fatality rate of up to 30%. Importantly, SFTSV is frequently transmitted from person-to-person and patients' blood or excreta are considered as the risk factors for transmission of SFTSV. However, the mechanism of person-to-person transmission of SFTSV is still elusive.

Methods

In this study, wild-type (WT) C57BL/6 J mice and a lethal SFTSV mouse model IFNAR−/− A129 mice were utilized to evaluate whether SFTSV could be transmitted via oral or ocular routes. C57BL/6 J mice were inoculated with cell-cultured SFTSV via oral and ocular inoculation. IFNAR−/− A129 mice were inoculated with cell-cultured SFTSV or SFTSV infected mouse acute sera via oral and ocular inoculation.

Results

We found that SFTSV antibody positive rates in C57BL/6 J mice were 70% (7/10) and 30% (3/10) in the oral inoculation group and ocular inoculation group, respectively on day 21 post SFTSV inoculation. The mortality rates of IFNAR−/− mice with oral and ocular inoculation of cell-cultured SFTSV were 100% and 83.33% (5/6), respectively on day 6 post inoculation. The mortality rates of IFNAR−/− mice with oral and ocular inoculation of SFTSV infected mouse acute serum were 100% and 66.67% (4/6), respectively on day 9 post inoculation.

Conclusions

Together, our results show that SFTSV can be transmitted effectively through oral and ocular membrane, suggesting exposure to SFTS positive excreta may be a high-risk factor of nosocomial transmission of SFTSV in hospitals and/or families. Family members and healthcare workers should be protected properly during taking care of SFTS patients to prevent SFTSV nosocomial infection.

Total 5